Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Medexus Pharmaceuticals Inc
MEDXF
Primary Symbol:
T.MDP
Healthcare
Medexus Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company with a North American commercial platform. The Company has a portfolio of rare disease treatment solutions. The Company is focused on the therapeutic areas of oncology, hematology, rheumatology, auto-immune diseases, allergy and dermatology. The Company has two divisions: Medexus Pharma Canada and Medexus Pharma USA...
. Medexus Pharma Canada division is a fully integrated commercial infrastructure focused on rheumatology, allergy, auto-immune disease, specialty oncology and pediatric diseases in Canada. The division’s prescription products include Metoject (Methotrexate Injection), Rupall (Rupatadine), Cuvposa (Glycopyrrolate Oral Solution), Pediapharm Naproxen Suspension (Naproxen) and others. Medexus Pharma USA division is a fully integrated commercial infrastructure focused on rheumatology and auto-immune diseases in the United States. The division’s products include Rasuvo, IXINITY and Gleolan.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:MDP)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(2137)
•••
nozzpack
X
View Profile
View Bullboard History
Post by
nozzpack
on Aug 04, 2023 1:06pm
Ebitda Sector Multiple
Approximately 13 times for this sector.. https://firstpagesage.com/business/pharmaceutical-company-valuation-ebitda-multiples/ Trailing, MDP had $16.1 million US in Ebitda in 2022 which
...more
(98)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Aug 04, 2023 12:00pm
Medexus to Participate in Fireside Chat at SHARE Series Even
JUST IN: $MEDXF Medexus to Participate in Fireside Chat at SHARE Series EventToronto, Ontario and Chicago, Illinois--(Newsfile Corp. - August 4, 2023) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX
...more
TAG Oil Announces Successful Production Test Results from BED4-T100 Horizontal Well
posted May 17, 2024 9:00am by
TAG Oil Ltd.
-
|
"We are pleased with the performance of our first well in the ARF resource play despite encountering drilling challenges resulting in a shorter lateral section of 308 meters. Looking ahead, TAG Oil plans to drill horizontal wells with lateral lengths of up to 1,000 meters, accompanied by three times ...read more
(2137)
•••
nozzpack
X
View Profile
View Bullboard History
Post by
nozzpack
on Aug 04, 2023 11:13am
Valuation shows substantial upside
so, $31 million is about $40 million in CAD . Annualized and assuming no further growth, that's bout $160 million per year . MDP has only 20.5 m shares so its current market cap at $3 per share
...more
(2137)
•••
nozzpack
X
View Profile
View Bullboard History
Post by
nozzpack
on Aug 04, 2023 11:02am
Q1 looks strong..Promoting it the next Week
ORIGINAL: Medexus to Participate in Fireside Chat at SHARE Series Event 2023-08-04 07:00 ET - News Release Toronto, Ontario and Chicago, Illinois--(Newsfile Corp
...more
(2137)
•••
nozzpack
X
View Profile
View Bullboard History
Post by
nozzpack
on Aug 04, 2023 11:00am
Q1 next Week
Medexus to release fiscal Q1 results Aug. 9 2023-08-02 13:51 ET - News Release Mr. Ken d'Entremont reports MEDEXUS SCHEDULES FIRST FISCAL QUARTER 2024 CONFERENCE
...more
(2137)
•••
nozzpack
X
View Profile
View Bullboard History
Post by
nozzpack
on Aug 04, 2023 10:58am
New..Scintillating Growth, growing profitability, solid cash
Medexus Pharmaceuticals Inc Symbol MDP Shares Issued 20,139,018 Close 2023-07-12 C$ 1.85
...more
(2)
•••
Paparico1
X
View Profile
View Bullboard History
Post by
Paparico1
on Jul 12, 2023 11:09pm
Let’s see what the market
Let’s see what the market says. Start trading under 1.80, we can see a rollover in the stock price.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jul 12, 2023 5:31pm
New Press Release - Medexus Announces Preliminary Revenue for Fiscal Q1 2024
Preliminary estimates indicate revenue is expected to exceed US$31 million for fiscal quarter ended June 30, 2023Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - July 12, 2023) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) is pleased to announce preliminary revenue estimates for...
read article.
(2)
•••
Paparico1
X
View Profile
View Bullboard History
Comment by
Paparico1
on Jul 06, 2023 3:27pm
RE:Good chance
Nice pull back, right down to the 50% retracement pretty much and filled in the gap too.
(2)
•••
Paparico1
X
View Profile
View Bullboard History
Post by
Paparico1
on Jul 04, 2023 6:38pm
Good chance
Good chance we pull back from this rally. From the low of 1.27 to high of 2.25 today. Daily Fibonacci retracement will be 38.2%~$1.88, 50% ~1.76$ or last would be 61.8% ~ 1.64 range
(2)
•••
Paparico1
X
View Profile
View Bullboard History
Comment by
Paparico1
on Jun 30, 2023 12:03pm
RE:Fibonacci retracement on weekly chart
There a big magnet at the Fibonacci retracement 61.8 area where the big gap happened in 2021. That could be the top of this run,5.50 to $6.20 area
(2)
•••
Paparico1
X
View Profile
View Bullboard History
Post by
Paparico1
on Jun 29, 2023 1:53pm
Fibonacci retracement on weekly chart
Fibonacci retracement on weekly chart From the 2021 high to 2022 low should be.... 38.2% 4.20$ 50% 5.18$ 61.8% 6.20
(3)
•••
existabo
X
View Profile
View Bullboard History
Comment by
existabo
on Jun 23, 2023 11:51am
RE:RE:RE:RE:October 16, 2023
look up Simply Wall Street, independant ( no broker) site that give fair valuation . Back to the chart ,we need good to great volume for a decent breakout.
(2)
•••
Paparico1
X
View Profile
View Bullboard History
Comment by
Paparico1
on Jun 22, 2023 6:52pm
RE:RE:RE:October 16, 2023
RSI at the same point in Oct 22ish, before it doubled in price. Volume is great too. MACD has been climbing positive since start of May. nice
(3)
•••
existabo
X
View Profile
View Bullboard History
Comment by
existabo
on Jun 22, 2023 4:15pm
RE:RE:October 16, 2023
On top of great results and financial strength, broker are going to look for action on M&A and ask their analyst to write it up. We need new buyer to push the 50 day moving aver. back up
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Xcyte Digital Corp. Releases "Xperience" Subscription Service
Drilling Approval Received for New Mexico Lithium Project
GameSquare Announces Formation of FaZe Media, Backed by $11M Investment